Microbot Medical Inc.
MBOT · XNASCIK 883975fmd_0ATFY6Q2C8C11FX1CRT92FJ5FP制造业 · 外科及医疗器械模板: 标准
覆盖范围: 2009年1月01日 至 2026年9月30日，共 67 个期间
| 项目 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | – | – | – | – | – | – | – | – | – | – |
| 营业成本 | – | – | – | – | – | – | – | – | – | – |
| 净利息收入 | – | 0 | 0 | – | – | – | – | – | – | – |
| 毛利润 | – | – | – | – | – | – | – | – | – | – |
| 研发费用 | (1) | 1 | 3 | 3 | 3 | 6 | 8 | 6 | 7 | 6 |
| 销售、一般及管理费用 | – | – | – | – | – | – | – | – | 5 | 8 |
| 营业费用合计 | – | – | – | – | – | – | – | – | – | – |
| 薪酬与福利 | – | – | – | – | 1 | 2 | 2 | – | – | – |
| 营业利润 | (10) | 5 | (7) | (7) | (9) | (11) | (13) | (10) | (12) | (15) |
| 利息费用 | 0 | 0 | – | – | – | – | – | – | – | – |
| 利息及投资收益 | – | – | – | – | – | – | – | – | – | – |
| 其他营业外收入（支出） | – | – | – | – | – | – | (0) | – | – | – |
| 税前利润 | – | – | – | – | – | – | – | – | – | – |
| 所得税费用 | – | – | – | 0 | 0 | – | – | – | – | – |
| 持续经营净利润 | – | – | – | – | – | – | – | – | – | – |
| 净利润 | (10) | (8) | (7) | (7) | (9) | (11) | (13) | (11) | (11) | (13) |
| 归属于普通股股东的净利润 | 6 | 6 | 7 | 7 | – | – | – | – | – | – |